Celldex Therapeutics buy Wells Fargo & Company
Start price
13.05.26
/
50%
€27.84
Target price
13.05.27
€46.01
Performance (%)
6.90%
Price
08:03
?
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan shows slight gains of 6.90%. This prediction currently runs until 13.05.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 4.080% | 4.080% |
| iShares Core DAX® | -0,32 % | -0,46 % |
| iShares Nasdaq 100 | -0,38 % | 1,36 % |
| iShares Nikkei 225® | -0,91 % | 9,39 % |
| iShares S&P 500 | 0,44 % | 0,81 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target raised by Wells Fargo & Company from $38.00 to $54.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.08.25
20.08.25
€32.67
20.08.26
20.08.26
61.74%
08:03
08:03
